Award
Delivery Order #SPE2DR26FT7FH
Delivery Order for Bupropion HCL SR Tablets under Pharmaceutical Services IDV
Buyer
Defense Logistics Agency
Award Amount
$41.32
Ceiling
$41.32
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FT7FH
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, under an existing Indefinite Delivery Vehicle (IDV) established for pharmaceutical procurement. The order pertains to the provision of Bupropion HCL SR 150 mg tablets, marking a specific pharmaceutical supply transaction within the broader contract framework. The supply of these tablets is critical to maintaining the consistent availability of essential medications for health services supported by the Department of Defense. The contract entails the delivery of this specified pharmaceutical product, ensuring timely fulfillment of healthcare requirements. This award follows a competitive acquisition process embedded within the IDV vehicle, leveraging the previous contractual relationship to streamline procurement. The short-term delivery timeline indicates a prompt fulfillment window, aligning with urgent or routine replenishment needs. This delivery order supports ongoing efforts to safeguard public and military health through reliable pharmaceutical supply chains.
Description
4570971676!BUPROPION HCL SR 150 MG TABLET 500S